Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementing Shared Decision Making (SDM) For HER2 Negative Metastatic Breast Cancer Patients (SDM-01 Study)

NCT07578415 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.

NCT NCT07578415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07578415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementing Shared Decision Making (SDM) For HER2 Negative Metastatic Breast Cancer Patients (SDM-01 Study)
Lead sponsor
Federico II University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
January 31, 2029
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, her2 negative breast cancer, metastatic breast cancer